p.E439Q | TCGA-D8-A1JA | BRCA | TCGA | SHMDCPVPTP | DEG_COP1_1 | 0.1389 |
p.E439Q | DO2819 | BRCA | ICGC | SHMDCPVPTP | DEG_COP1_1 | 0.1389 |
p.H418Y | TCGA-EE-A29E | SKCM | TCGA | SHMDCPVPTP | DEG_COP1_1 | 0.1944 |
p.H418Y | DO37831 | SKCM | ICGC | SHMDCPVPTP | DEG_COP1_1 | 0.1944 |
p.F434V | TCGA-EO-A22R | UCEC | TCGA | SHMDCPVPTP | DEG_COP1_1 | 0.2778 |
p.F434V | DO42713 | UCEC | ICGC | SHMDCPVPTP | DEG_COP1_1 | 0.2778 |
p.P432H | TCGA-EY-A215 | UCEC | TCGA | SHMDCPVPTP | DEG_COP1_1 | 0.7694 |
p.P432H | DO42665 | UCEC | ICGC | SHMDCPVPTP | DEG_COP1_1 | 0.7694 |
p.G433D | SIDM00683 | Prostate Carcinoma | GDSC | SHMDCPVPTP | DEG_COP1_1 | 0.3056 |
p.G433D | LNCaP-Clone-FGC | prostate | COSMIC | SHMDCPVPTP | DEG_COP1_1 | 0.3056 |
p.A420T | SIDM00951 | T-Lymphoblastic Leukemia | GDSC | SHMDCPVPTP | DEG_COP1_1 | 0.25 |
p.A420T | ACH-001737 | Leukemia | CCLE | SHMDCPVPTP | DEG_COP1_1 | 0.25 |
p.A420T | ACH-002222 | Leukemia | CCLE | SHMDCPVPTP | DEG_COP1_1 | 0.25 |
p.A420T | CTV-1 | haematopoietic_and_lymphoid_tissue | COSMIC | SHMDCPVPTP | DEG_COP1_1 | 0.25 |
p.H418R | ACH-001510 | Head and Neck Cancer | CCLE | SHMDCPVPTP | DEG_COP1_1 | 0.1944 |